Comparison of Improvements in Quality of Life With Disease-Modifying Anti-rheumatic Drugs in Seropositive and Seronegative Rheumatoid Arthritis
Early initiation of csDMARDs in RA patients leads to significant improvement in QoL, regardless of serostatus. While both groups benefited similarly in HRQoL, seronegative patients experienced greater reductions in pain and disease activity, underscoring the efficacy of csDMARDs as an initial treatment strategy in RA management.
Authors
- M. A. Shalu
- Avinash Muraleedharan
- Ashish Yadav
- Shweta Chaubey
Institutions
- All India Institute of Medical Sciences Raipur (IN)
- Government Medical College (IN)
- Nagpur Institute of Technology (IN)
- Bangalore Baptist Hospital (IN)
- Central India Institute of Medical Sciences (IN)
- National Rehabilitation Center for Persons with Disabilities (JP)
- All India Institute of Medical Sciences, Nagpur (IN)
Publication Details
- Journal
- Cureus
- Published
- 2025-12-25
- DOI
- https://doi.org/10.7759/cureus.100094
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00